Medication info
Mighty Set Semicapsule (Tramadol Hydrochloride, Acetaminophen)

Mighty Set Semicapsule (Tramadol Hydrochloride, Acetaminophen)

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›18.75mg / 1 tabletAcetaminophen›162.5mg / 1 tablet
Manufacturer / importer
HLB Pharma Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201803289 · Approved 2018.08.13 · Insurance code 647303460

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: Administer the lowest effective dose for the shortest possible duration. Do not administer this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Older adults Use the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Tramadol is removed very slowly during hemodialysis and filtration; therefore, this medicine does not need to be readministered after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Pediatric patients aged 12 years and older: An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, not exceeding 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not administer this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
HLB Pharma Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate pain
  • severe pain
  • acute pain
  • chronic pain
View approved original text

This medication is used for the relief of acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: Administer the lowest effective dose for the shortest possible duration. Do not administer this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Older adults Use the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Tramadol is removed very slowly during hemodialysis and filtration; therefore, this medicine does not need to be readministered after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Pediatric patients aged 12 years and older: An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, not exceeding 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not administer this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication may burden the liver, so individuals who regularly consume more than three drinks of alcohol per day must consult their doctor or pharmacist. The acetaminophen component can rarely cause serious skin reactions, so if skin rashes or hypersensitivity reactions occur, discontinue use immediately. The tramadol component may increase the risk of seizures if taken above the recommended dose, and the risk of seizures may further increase when taken with certain antidepressants or narcotics. For patients with severe respiratory diseases, this medication may cause respiratory depression, which can be life-threatening, so it must be administered in an adequately equipped facility. Combining this medication with alcohol or central nervous system depressants can lead to severe sedation, respiratory depression, or coma, so caution is advised. Patients with increased intracranial pressure or head injuries may experience worsened symptoms when taking this medication. The tramadol component can cause psychological and physical dependence; therefore, careful monitoring of dependence should be conducted during long-term use. Patients with impaired liver function should consult their doctor before taking this medication, as excessive intake of acetaminophen can lead to severe liver damage. Particularly for ultra-rapid metabolizers of CYP2D6, the concentration of the active metabolite can increase, raising the risk of respiratory depression, requiring caution. This medication should not be administered to children, especially those under 12 years of age or teenagers under 18 who have undergone tonsillectomy and adenoidectomy. It may induce sleep apnea or hypoxia, so continuous monitoring for these symptoms, or any worsening of them, is necessary. Patients at risk for hyponatremia should monitor for symptoms of hyponatremia while taking this medication. This medication is contraindicated in certain patient populations, for example, those with hypersensitivity to the components, severe respiratory depression, head injuries, or those taking MAO inhibitors should not take this medication. Patients taking narcotic analgesics or central nervous system depressants, those with severe liver or kidney dysfunction, and those with alcohol dependence should use caution when taking it. This medication may cause drowsiness or dizziness, so caution should be exercised when driving or operating machinery. In case of overdose, serious side effects such as respiratory depression, seizures, or liver damage may occur; therefore, the dosage must be strictly adhered to, and in case of overdose, medical attention should be sought immediately. Women who are pregnant or breastfeeding should consult their doctor before taking this medication, and breastfeeding mothers should avoid this medication as it is safer not to take it. During the use of this medication, if abnormal symptoms such as seizures, allergic reactions, or difficulty breathing appear, inform healthcare personnel immediately.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, stupor, fatal respiratory depression, hyponatremia, appetite loss, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory loss, tremors, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, diaphoresis, urination disorders, erectile dysfunction, asthenia, chest pain, abnormal emotions, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal ideation, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, hematological disorders, thrombocytopenia, anemia, decreased hemoglobin, decreased red blood cells, leukopenia, leukocytosis, congestive heart failure, vertigo, confusion, worsening of migraines, involuntary muscle contractions, vaginal bleeding, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, cholecystitis, paralytic ileus, hiccups, abnormal renal function tests, increased saliva

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. Additionally, avoid extremely hot or cold locations, and it is advisable to store it at a temperature between 1 to 30 degrees Celsius, which is typical room temperature.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.